STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #318 by analyst upside · 2026-08-13
RMTI
Rockwell Medical, Inc.
Healthcare · Market Cap $30M · P/E 0x
ANALYST PRICE TARGET
+299.5%
implied upside to consensus target
Current Price $7.51
Consensus Target $30.0
Bull Target $40.0
Bear Target $20.0
Analysts Covering 2
ANALYST CONSENSUS - STRONG BUY
Strong Buy
1
Buy
1
Hold
0
Sell
0
52-Week Low $4.89
52-Week High $21.0
YTD Return -12.7%
FUNDAMENTALS
Market Cap $30M
P/E Ratio (TTM) N/A
Forward P/E 107.3x
EPS (TTM) $-1.50
PEG Ratio 4.43
Dividend Yield N/A
Revenue (TTM) $68M
Profit Margin -8.0%
52-WEEK RANGE
52-Week Low $4.89
52-Week High $21.0
Current Price $7.51
Bear Target $20.0
Bull Target $40.0
● Now $7.51 ● Target $30.0
TRADING DATA
Avg Volume 35K
YTD Return -12.7%
Analyst Count 2
Consensus Strong Buy
Upside to Target +299.5%
Last Updated 2026-08-13

ANALYST SUMMARY

Rockwell Medical, Inc. (RMTI) is currently trading at $7.51 with a Wall Street consensus price target of $30.0, implying potential upside of 299.5% over the next 12 months. 2 analysts currently cover RMTI, with a consensus rating of Strong Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $40.0, while the most cautious has a target of $20.0.

RMTI operates in the Healthcare sector with a market capitalisation of $30M. The stock is down 12.7% year-to-date and is currently trading near the lower end of its 52-week range of $4.89 – $21.0.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for RMTI, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. - Reiterated
Buy → Buy 2026-03-30 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-01-26 31% win rate (48 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2025-11-13 31% win rate (48 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2025-03-24 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2024-12-23 31% win rate (48 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2024-11-25 31% win rate (48 calls)
Rodman & Renshaw ● Initiated
Buy 2024-11-14 29% win rate (7 calls)
HC Wainwright & Co. reit
Buy → Buy 2024-08-12 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
35
out of 100
Coverage depth
8/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →